Companies Dabur India Ltd FollowOct 19 (Reuters) - Dabur India (DABU.NS) said on Wednesday its subsidiaries were among companies sued in the U.S. and Canada by customers alleging that the use of hair relaxer products had caused ovarian cancer, uterine cancer and other health issues.
They were last down 1.7% at 525 rupees as of 12:06 p.m. IST, extending their year-to-date decline to 6.5%.
The units have denied liability and have retained counsel to defend them, the company said.
The company did not immediately respond to a request for additional details outside of normal business hours.
Reporting by Kanjyik Ghosh in Bengaluru; Editing by Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.
Persons:
Kanjyik Ghosh, Sriraj
Organizations:
Dabur, Namaste Laboratories, Thomson
Locations:
India, U.S, Canada, Illinois, Bengaluru